January 11, 2008 -- Benda Pharmaceutical (OTCBB: BPMA) announced that its newly expanded Ebei manufacturing facility has begun production, raising the company’s ability to increase its revenues. In November, one of five new production lines received Good Manufacturing Practices (GMP) certification. The line, which produces tablets, has the ability to manufacture $1.8 million worth of product. Production began in December. More details...
